Skip to content

IVY RX review

A low starting price for compounded GLP-1s, fast online approval and no lab requirement, plus Ozempic and Mounjaro at $1,399 each. Its help center still makes a sameness claim FDA objects to, and it takes no insurance.

Research-based review: nobody from GLPLens signed up, paid or received medication. Everything below comes from IVY RX's own pages and FDA, read Sep 27, 2026. How we score.

65 / 100

What it prescribes
25 / 40 Brand-name and compounded versions
Published prices
10 / 20 Some prices published
Commitment
20 / 20 Cancel anytime
Insurance
0 / 10 Self-pay only
Where it operates
10 / 10 All 50 states

Website: ivyrx.com. We do not link to it: it sells compounded GLP-1s. Brand-name options: the price table.

Good

  • Low advertised starting price for compounded GLP-1 injections
  • Says you can cancel at any time with no cancellation fee
  • Says it connects patients with clinicians in all 50 states
  • No FDA warning letter to IVY RX found in FDA's database

Watch out for

  • Most of its GLP-1 range is compounded, which FDA does not approve
  • Help-center article compares its compounded drug to brand names in a way FDA has flagged at other firms
  • Offers Ozempic and Mounjaro, which are diabetes drugs, for weight loss
  • No insurance accepted and all sales are final

What it is

IVY RX is an online telehealth platform for weight loss, anti-aging and sexual health. It says it connects patients with licensed clinicians in all 50 states [1]. Prescriptions go to its partner pharmacies, which ship to your home.

What it prescribes

Most of its weight-loss range is compounded: semaglutide and tirzepatide injections, a lower-dose “microdose” injection and dissolving oral melts. Its own disclaimer says compounded medications have not been FDA-regulated for safety, effectiveness or quality [2].

It also lists two brand-name drugs, Ozempic and Mounjaro, at $1,399 each [3] [4]. Both are FDA-approved to improve blood sugar in type 2 diabetes [5], and Lilly states that Mounjaro is not a weight loss drug [6]. IVY RX nonetheless markets Ozempic “for weight loss” in its help center [7]. If weight loss is your goal, the GLP-1s FDA has approved for it include Wegovy, Zepbound and Foundayo; see what each GLP-1 is approved for.

What it costs

Compounded GLP-1 injections are advertised from $77, described as 4 doses a month [8]. That is a starting figure; the product page does not list the price at each plan or dose. The page does promise the same price at every dose and says no insurance is needed [9]. IVY RX does not accept any public or private insurance, so the brand-name drugs above are cash prices too [10].

Signing up and cancelling

Approval is online and the product page says lab work is not needed [11]. Its terms describe two billing options, one month or three months prepaid, each renewing month to month afterward [12]. The help center says you may cancel at any time with no cancellation fee [13], and that you must check in with your provider each month before the next order is billed and shipped [14]. Refunds are another matter: all transactions are final [15].

Safety and regulatory record

We searched FDA’s warning letter database for IVY RX and found no letter. One thing on its own site stands out, though. A help-center article on its compounded semaglutide program still says the product has the same active ingredient as two brand-name drugs [16]. In its 2026 round of warning letters to telehealth firms, FDA said a main violation was claims implying sameness with FDA-approved products [17]. A compounded drug is not the same as, or a copy of, an approved brand.

Who it suits, and who should look elsewhere

IVY RX suits a cash buyer who has chosen a compounded GLP-1 and wants a low entry price with no lab step. Look elsewhere if you want an FDA-approved weight-loss drug at a lower cash price than $1,399, or if you need insurance to pay [3]. Our brand-name cash price guide lists cheaper direct-from-manufacturer options.

Sources

  1. IVY RX is a 100% online telehealth platform that connects patients to vetted, licensed healthcare professionals in all 50 states. support.ivyrx.com, read Sep 27, 2026.
  2. Compounded medications may be prescribed by physicians, but have not been FDA-regulated for safety, effectiveness, or quality. ivyrx.com, read Sep 27, 2026.
  3. $1,399 Ozempic® (Semaglutide) ivyrx.com, read Sep 27, 2026.
  4. $1,399 Mounjaro® (Tirzepatide) ivyrx.com, read Sep 27, 2026.
  5. prescription medicines used: along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes ozempic.com, read Sep 27, 2026.
  6. Mounjaro is not a weight loss drug. mounjaro.lilly.com, read Sep 27, 2026.
  7. Introducing Ozempic® for weight loss, an FDA-approved Semaglutide (GLP-1) injection support.ivyrx.com, read Sep 27, 2026.
  8. From $77 (4 doses/month) GLP-1 Weight Loss Medication ivyrx.com, read Sep 27, 2026.
  9. Same price, every dose (no surprises, no insurance needed) ivyrx.com, read Sep 27, 2026.
  10. We do not accept any public or private health insurance plans, cost-sharing, or any other similar methods of payment. support.ivyrx.com, read Sep 27, 2026.
  11. Labwork isn’t needed (faster access to medication) ivyrx.com, read Sep 27, 2026.
  12. you must subscribe to Ivy Rx for a period of either (a) one (1) month pre-paid with a month-to-month autorenewal, or (b) three (3) months pre-paid with a month-to-month autorenewal. ivyrx.com, read Sep 27, 2026.
  13. Yes, you may cancel at any time. We understand circumstances can change, so there are no long-term commitments or cancellation fees. support.ivyrx.com, read Sep 27, 2026.
  14. You will need to check in with your provider every month before billing and shipping can occur. support.ivyrx.com, read Sep 27, 2026.
  15. Unfortunately, we are unable to provide reimbursements or receive back prescription products for reuse or resale, and all transactions are considered final. support.ivyrx.com, read Sep 27, 2026.
  16. Note: This medication contains the same active ingredient as Wegovy® and Ozempic®. support.ivyrx.com, read Sep 27, 2026.
  17. Primary violations identified in the letters included making claims implying sameness with FDA-approved products and obscuring product sourcing by advertising drug products branded with the telehealth firm's name or trademark without qualification, implying they are the compounder. fda.gov, read Sep 27, 2026.

Other reviews: all programs, scored the same way. Real users' experiences: reader stories.